Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

SODIUM CHLORIDE

×

Overview

What is HAEMONETICS 0.9 % Sodium Chloride?

Sodium Chloride Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in a single dose container for intravenous administration. It contains no antimicrobial agents. The pH is 4.5 to 7.0. Composition, osrnolarity, and ionic concentration are shown below:  0.9% Sodium Chloride Injection, USP contains 9 g/L. Sodium Chloride, USP (NaCl) with an osmolarity of 308 mOsmol/L (cale). It contains 154 mEq/L sodium and 154 mEQ/L chloride.  The amount of water that can permeate from inside the container into the overlap in insufficient to affect the solution significantly.  Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexyl phthalate (DEHP) up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity studies.



What does HAEMONETICS 0.9 % Sodium Chloride look like?



What are the available doses of HAEMONETICS 0.9 % Sodium Chloride?

Sorry No records found.

What should I talk to my health care provider before I take HAEMONETICS 0.9 % Sodium Chloride?

Sorry No records found

How should I use HAEMONETICS 0.9 % Sodium Chloride?

Sodium Chloride Injection, USP is indicated as a source of water and electrolytes. 0.9% Sodium Chloride in hemodialysis procedures.

As directed by a physician. Dosage is dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations.  Parenteral drug products should be inspected visually for participate matter and discoloration prior to administration whenever solution and container permit.  All injections in plastic containers are intended for intravenous administration using sterile equipment. Additives may be incompatible. Complete information is not available. Those additives known to be incompatible should not be used. Consult with pharmacist, if available. If, in the informed judgment of the physician, it is deemed advisable to introduce additives, use aseptic techniques. Mix thoroughly when additives have been introduced. Do not store solutions containing additives.


What interacts with HAEMONETICS 0.9 % Sodium Chloride?

Sorry No Records found


What are the warnings of HAEMONETICS 0.9 % Sodium Chloride?

Sorry No Records found


What are the precautions of HAEMONETICS 0.9 % Sodium Chloride?

Sorry No Records found


What are the side effects of HAEMONETICS 0.9 % Sodium Chloride?

Sorry No records found


What should I look out for while using HAEMONETICS 0.9 % Sodium Chloride?

None Known

Sodium Chloride Injection, USP should be used with great care, if at all, in patients with congestive heart failure, servere renal insufficiency, and in clinical states in which there exist ederna with sodium retention. In patients with diminshed renal function administration of Sodium Chloride Injection, USP may result in sodium retention.


What might happen if I take too much HAEMONETICS 0.9 % Sodium Chloride?

Sorry No Records found


How should I store and handle HAEMONETICS 0.9 % Sodium Chloride?

Store at 500mL of 0.9% Sodium Chloride Injection, USP are contained in a flexible plastic bag and individually overwrapped. The Product Code is 441A and the NDC is 057826 441.  Exposure of pharmaceutical products to beat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25 degree C): brief exposure up to 40 C does not adversely affect the product.


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Sodium Chloride Injection, USP has value as a source of water and electrolytes. It is capable of inducing diuresis depending on the clinical condition of the patient.

Non-Clinical Toxicology
None Known

Sodium Chloride Injection, USP should be used with great care, if at all, in patients with congestive heart failure, servere renal insufficiency, and in clinical states in which there exist ederna with sodium retention. In patients with diminshed renal function administration of Sodium Chloride Injection, USP may result in sodium retention.

Clinically meaningful drug interactions have occurred with concomitant medications and include (but are not limited to) the following:

Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.  Caution must be exercised in the administration of Sodium Chloride Injection, USP to patients receiving corticosteroids or corticotrophin.

Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic counter measures and save the remainder of the fluid for examination if deemed necessary.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).